Inventor
STOEHR HANS-ARNOLD
DE20 patents
⚠️ This page may combine multiple inventors who share the name “STOEHR HANS-ARNOLD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CSL BEHRING GMBH
8 patentsUS7879803B2Feb 1, 2011
Methods of treatment involving the protease for activating clotting factor VII
CSL BEHRING GMBH0 citations51
US10232015B2Mar 19, 2019
Sugar compositions for treating hemophilia A and/or Von Willebrand disease
CSL BEHRING GMBH0 citations50
US9707269B2Jul 18, 2017
Sugar compositions for treating hemophilia A and/or von Willebrand disease
CSL BEHRING GMBH0 citations50
US7863009B2Jan 4, 2011
Mutants of the factor VII-activating protease and detection methods using specific antibodies
CSL BEHRING GMBH0 citations49
US7442514B2Oct 28, 2008
Mutants of the factor VII-activating protease and detection methods using specific antibodies
CSL BEHRING GMBH0 citations49
US7803569B2Sep 28, 2010
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations
CSL BEHRING GMBH0 citations47
US7829095B2Nov 9, 2010
Inhibitory monoclonal antibody against blood clotting factor VII-activating protease
CSL BEHRING GMBH0 citations45
US7892842B2Feb 22, 2011
Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
CSL BEHRING GMBH0 citations41
AVENTIS BEHRING GMBH
7 patentsUS6737405B2May 18, 2004
Stabilized protein preparation and process for its preparation
AVENTIS BEHRING GMBH55 citations95
US6677440B1Jan 13, 2004
Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
AVENTIS BEHRING GMBH22 citations92
US6528299B1Mar 4, 2003
Protease for activating clotting factor VII
AVENTIS BEHRING GMBH22 citations92
US6670455B1Dec 30, 2003
Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography
AVENTIS BEHRING GMBH12 citations73
US6831167B2Dec 14, 2004
Mutants of the factor VII-activating protease and detection methods using specific antibodies
AVENTIS BEHRING GMBH9 citations71
US7153679B2Dec 26, 2006
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis
AVENTIS BEHRING GMBH9 citations69
US6573056B2Jun 3, 2003
Process for purifying factor VII and activated factor VII
AVENTIS BEHRING GMBH3 citations62